ARCHIVES

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 37 No. 24 | June 17, 2011

Download PDF Visit The Full Archive

Related Articles

Anidulafungin Safe And Well-Tolerated In Pediatric Patients With Neutropenia

November 26, 2004

Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing

October 15, 2010

Grant Applications Pour Into NCI, NIH; Downward Trend In Funding Due To Be Reversed In FY 1979

June 16, 1978

UC Davis Coordinates Asian American Network

September 27, 2002

CCOP Reviewers Briefed On Program Objective, Criteria

January 7, 1983

DCBD Concepts Approved

November 8, 1985